Literature DB >> 21468696

Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study.

Michela Basileo1, Carlo Micheluzzi, Marina Minozzi, Luigi Lazzaroni, Alfonso Iorio.   

Abstract

The number of patients on oral anticoagulant therapy has increased in recent years, and this trend is expected to continue. The increased workload for physicians has led to the development of computerized systems to make organizational workflow more efficient. These programs may include algorithms to propose a weekly dosage and timing for the following visit. Before introducing a new algorithm in clinical practice, its safety and efficacy must be validated. We undertook a retrospective simulation study to test a new algorithm for the TAOnet system. The main outcome was the percentage of concordant and discordant proposals between manual- and algorithm-based prescriptions. Pairs of computerized and physician prescriptions were assessed. They were categorized as 0.1-5, 5.1-10 and >10% if the dose was different, and assigned as "algorithm better" or "manual better" dependent upon the subsequent international normalized ratio value. In 61.0% of cases, the manual and computerized weekly dosage assignments were identical; in 15.3% of cases, the difference was between 0.1 and 5%; in 14.7 of cases, it was between 5.1 and 10%; and in 9.0% of cases, it was >10%. The algorithm did better in 43.9% of discordant pairs, generally due to less frequent under-dosing. In conclusion, the new algorithm proved to consistently overlap with the manual method. The algorithm is useful but must be tested in a multi-center, prospective, interventional study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468696     DOI: 10.1007/s11739-011-0581-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  18 in total

1.  A model-based algorithm for the monitoring of long-term anticoagulation therapy.

Authors:  E Pasterkamp; C J Kruithof; F J M Van der Meer; F R Rosendaal; J P M Vanderschoot
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

2.  Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

Authors:  L Poller; C R Shiach; P K MacCallum; A M Johansen; A M Münster; A Magalhães; J Jespersen
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

3.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

Review 4.  Computer assisted anticoagulant therapy.

Authors:  C Manotti; C Pattacini; R Quintavalla; A Tagliaferri; M Lombardi; M Tassoni
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

5.  Improved control of oral anticoagulant dosing: a randomized controlled trial comparing two computer algorithms.

Authors:  Y van Leeuwen; E K Rombouts; C J Kruithof; F J M van der Meer; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2007-05-07       Impact factor: 5.824

Review 6.  Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.

Authors:  Katherine W Phillips; Jack Ansell
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-01

7.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

8.  An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage.

Authors:  L Poller; M Keown; S Ibrahim; G Lowe; M Moia; A G Turpie; C Roberts; A M H P van den Besselaar; F J M van der Meer; A Tripodi; G Palareti; C Shiach; S Bryan; M Samama; M Burgess-Wilson; A Heagerty; P Maccallum; D Wright; J Jespersen
Journal:  J Thromb Haemost       Date:  2008-06       Impact factor: 5.824

Review 9.  Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.

Authors:  Maarten Beinema; Jacobus R B J Brouwers; Tom Schalekamp; Bob Wilffert
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

Review 10.  New oral anticoagulants in development.

Authors:  Jeffrey I Weitz
Journal:  Thromb Haemost       Date:  2009-10-26       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.